We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

28 hedge funds and large institutions have $34.2K invested in Ampio Pharmaceuticals Inc. in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

3% less funds holding

Funds holding: 2928 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

67% less capital invested

Capital invested by funds: $102K → $34.2K (-$68.3K)

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

AMPE Hedge Fund Activity: Q1 2024 in Review

28 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2024, worth a combined $34.2K — down 67% from $102K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AMPE and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $33.1K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $40.1K sold.

  • 28 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2024, down from 29 in Q4 2023.
  • Funds reported $34.2K of Ampio Pharmaceuticals Inc. stock for Q1 2024, down 67% quarter-over-quarter.
  • 2 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2024 and 3 closed out, a net change of -1 holder.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2024 was Virtu Financial, an estimated $33.1K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2024 was Susquehanna International Group, an estimated $40.1K sold.

Based on aggregated 13F filings for Q1 2024.